Privi SpecialityChem
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 11 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
RECOMMENDS FINAL DIVIDEND OF 10 RUPEES PER SHARE FOR FY 2025-26
MARCH-QUARTER CONSOL NET PROFIT 937 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 7.22 BILLION RUPEES
Source text: ID:nBSE43NZng
Further company coverage: PIVI.NS
(([email protected];))
May 11 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
RECOMMENDS FINAL DIVIDEND OF 10 RUPEES PER SHARE FOR FY 2025-26
MARCH-QUARTER CONSOL NET PROFIT 937 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 7.22 BILLION RUPEES
Source text: ID:nBSE43NZng
Further company coverage: PIVI.NS
(([email protected];))
Feb 9 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL NET PROFIT 779.9 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 6.05 BILLION RUPEES
Source text: ID:nnAZN4SFLEM
Further company coverage: PIVI.NS
(([email protected];))
Feb 9 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL NET PROFIT 779.9 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 6.05 BILLION RUPEES
Source text: ID:nnAZN4SFLEM
Further company coverage: PIVI.NS
(([email protected];))
** Shares of Privi Specialty Chemicals PIVI.NS rise as much as 5.5% to 1,808 rupees, highest since May 5, 2022
** Co said on Thursday its consol net profit rose 46% to 446.6 mln rupees ($5.31 mln) Y/Y
** Rev from ops up 17%
** More than 138,000 shares change hands, 2.7x its 30-day avg
** Stock up 50% so far this year
($1 = 84.0480 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Privi Specialty Chemicals PIVI.NS rise as much as 5.5% to 1,808 rupees, highest since May 5, 2022
** Co said on Thursday its consol net profit rose 46% to 446.6 mln rupees ($5.31 mln) Y/Y
** Rev from ops up 17%
** More than 138,000 shares change hands, 2.7x its 30-day avg
** Stock up 50% so far this year
($1 = 84.0480 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
Oct 10 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT API, REGISTRATION CERTIFICATE FOR ITS CAMPHOR PRODUCT FROM US FDA
Source text for Eikon: ID:nNSE87yk3z
Further company coverage: PIVI.NS
(([email protected];))
Oct 10 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT API, REGISTRATION CERTIFICATE FOR ITS CAMPHOR PRODUCT FROM US FDA
Source text for Eikon: ID:nNSE87yk3z
Further company coverage: PIVI.NS
(([email protected];))
** Shares of Privi Speciality Chemicals PIVI.NS rise as much as 5.8% to 1,720 rupees
** Stock hits highest since Sept 2022, eyes fourth straight session of gains
** Aroma and fragrance chemicals maker reports near 7-fold jump in Q1 consolidated net profit
** More than 206,000 shares traded, 3.3x the 30-day avg
** Stock last up 2%, taking YTD gains to 40.8%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
** Shares of Privi Speciality Chemicals PIVI.NS rise as much as 5.8% to 1,720 rupees
** Stock hits highest since Sept 2022, eyes fourth straight session of gains
** Aroma and fragrance chemicals maker reports near 7-fold jump in Q1 consolidated net profit
** More than 206,000 shares traded, 3.3x the 30-day avg
** Stock last up 2%, taking YTD gains to 40.8%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT GOVERNMENT CONFERRED STATUS OF ULTRA MEGA PROJECT
Source text for Eikon: ID:nBSE3L6Sgt
Further company coverage: PIVI.NS
Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT GOVERNMENT CONFERRED STATUS OF ULTRA MEGA PROJECT
Source text for Eikon: ID:nBSE3L6Sgt
Further company coverage: PIVI.NS
June 24 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO IS EXPLORING STRATEGIC INVESTMENT IN PRIVI FINE SCIENCES
DEAL FOR 2.98 BILLION RUPEES
Source text for Eikon: ID:nBSE7KfvzN
Further company coverage: PIVI.NS
(([email protected];;))
June 24 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO IS EXPLORING STRATEGIC INVESTMENT IN PRIVI FINE SCIENCES
DEAL FOR 2.98 BILLION RUPEES
Source text for Eikon: ID:nBSE7KfvzN
Further company coverage: PIVI.NS
(([email protected];;))
May 2 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
DIVIDEND 2 RUPEES PER SHARE
REAPPOINTED MAHESH P BABANI AS A CHAIRMAN AND MANAGING DIRECTOR OF CO
MARCH-QUARTER CONSOL NET PROFIT 310.2 MILLION RUPEES VERSUS LOSS 136.8 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.84 BILLION RUPEES VERSUS 3.99 BILLION RUPEES
APPROVED TO ISSUE SECURITIES WORTH UPTO 10 BILLION RUPEES
Further company coverage: PIVI.NS
(([email protected];))
May 2 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
DIVIDEND 2 RUPEES PER SHARE
REAPPOINTED MAHESH P BABANI AS A CHAIRMAN AND MANAGING DIRECTOR OF CO
MARCH-QUARTER CONSOL NET PROFIT 310.2 MILLION RUPEES VERSUS LOSS 136.8 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.84 BILLION RUPEES VERSUS 3.99 BILLION RUPEES
APPROVED TO ISSUE SECURITIES WORTH UPTO 10 BILLION RUPEES
Further company coverage: PIVI.NS
(([email protected];))
April 22 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS LTD - TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE9BbqcJ
Further company coverage: PIVI.NS
(([email protected];))
April 22 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS LTD - TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE9BbqcJ
Further company coverage: PIVI.NS
(([email protected];))
** Shares of Ami Organics AMIO.NS up as much as 2.8% to 1,255 rupees; last up 1.7%
** The speciality chemicals maker on Friday approved raising 5 bln rupees ($59.9 mln) via qualified institutional placement (QIP) of shares
** Average rating of five analysts covering the stock is "buy"; median PT is 1,315 rupees - LSEG data
** Including session's moves, AMIO up ~11% this year, far outpacing rivals Privi Speciality Chemicals PIVI.NS and Tatva Chintan Pharma Chem TATV.NS, which are down between 7.1%-21.8%
($1 = 83.4300 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of Ami Organics AMIO.NS up as much as 2.8% to 1,255 rupees; last up 1.7%
** The speciality chemicals maker on Friday approved raising 5 bln rupees ($59.9 mln) via qualified institutional placement (QIP) of shares
** Average rating of five analysts covering the stock is "buy"; median PT is 1,315 rupees - LSEG data
** Including session's moves, AMIO up ~11% this year, far outpacing rivals Privi Speciality Chemicals PIVI.NS and Tatva Chintan Pharma Chem TATV.NS, which are down between 7.1%-21.8%
($1 = 83.4300 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of Privi Speciality Chemicals PIVI.NS close up 1.5% after co posts strong Q3 profit
** Aroma and fragrance chemicals maker reports Q3 net profit of 287.6 mln rupees ($3.5 mln), up nearly 4.5x YoY
** Rev from ops fell 3.8%, but expenses fell 11.4%
** Stock up for a fourth consecutive session, closes above 50- and 100-day avgs for first time in over a month
** Stock fell 3.4% in Q3 FY24
($1 = 83.0800 Indian rupees)
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of Privi Speciality Chemicals PIVI.NS close up 1.5% after co posts strong Q3 profit
** Aroma and fragrance chemicals maker reports Q3 net profit of 287.6 mln rupees ($3.5 mln), up nearly 4.5x YoY
** Rev from ops fell 3.8%, but expenses fell 11.4%
** Stock up for a fourth consecutive session, closes above 50- and 100-day avgs for first time in over a month
** Stock fell 3.4% in Q3 FY24
($1 = 83.0800 Indian rupees)
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
Aug 7 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO INVESTED SECOND TRANCHE OF 36.5 MILLION RUPEES IN SPV
Source text for Eikon: ID:nNSE8tv3wV
Further company coverage: PIVI.NS
(([email protected];))
Aug 7 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO INVESTED SECOND TRANCHE OF 36.5 MILLION RUPEES IN SPV
Source text for Eikon: ID:nNSE8tv3wV
Further company coverage: PIVI.NS
(([email protected];))
May 29 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INDIA'S PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL NET LOSS 136.8 MILLION RUPEES VERSUS PROFIT 299.1 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.99 BILLION RUPEES VERSUS 3.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
May 29 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INDIA'S PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL NET LOSS 136.8 MILLION RUPEES VERSUS PROFIT 299.1 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.99 BILLION RUPEES VERSUS 3.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
May 4 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INVESTED FIRST TRANCHE OF 1 MILLION RUPEES BY SUBSCRIBING TO SHARES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
May 4 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INVESTED FIRST TRANCHE OF 1 MILLION RUPEES BY SUBSCRIBING TO SHARES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Privi SpecialityChem do?
Privi Speciality Chemicals Ltd is a leading Indian manufacturer and exporter of aroma and fragrance chemicals, known for its advanced R&D, sustainable practices, strong global presence, and long-term partnerships with leading FMCG and fragrance companies.
Who are the competitors of Privi SpecialityChem?
Privi SpecialityChem major competitors are SH Kelkar & Company, Oriental Aromatics, Atul, Clean Science & Tech, Rossari Biotech. Market Cap of Privi SpecialityChem is ₹14,434 Crs. While the median market cap of its peers are ₹2,912 Crs.
Is Privi SpecialityChem financially stable compared to its competitors?
Privi SpecialityChem seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Privi SpecialityChem pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Privi SpecialityChem latest dividend payout ratio is 11.93% and 3yr average dividend payout ratio is 10.2%
How has Privi SpecialityChem allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable
How strong is Privi SpecialityChem balance sheet?
Balance sheet of Privi SpecialityChem is strong. But short term working capital might become an issue for this company.
Is the profitablity of Privi SpecialityChem improving?
Yes, profit is increasing. The profit of Privi SpecialityChem is ₹328 Crs for Mar 2026, ₹187 Crs for Mar 2025 and ₹94.91 Crs for Mar 2024
Is the debt of Privi SpecialityChem increasing or decreasing?
The net debt of Privi SpecialityChem is decreasing. Latest net debt of Privi SpecialityChem is ₹838 Crs as of Mar-26. This is less than Mar-25 when it was ₹1,006 Crs.
Is Privi SpecialityChem stock expensive?
Privi SpecialityChem is not expensive. Latest PE of Privi SpecialityChem is 44.07, while 3 year average PE is 78.07. Also latest EV/EBITDA of Privi SpecialityChem is 23.76 while 3yr average is 25.48.
Has the share price of Privi SpecialityChem grown faster than its competition?
Privi SpecialityChem has given better returns compared to its competitors. Privi SpecialityChem has grown at ~35.48% over the last 4yrs while peers have grown at a median rate of -12.38%
Is the promoter bullish about Privi SpecialityChem?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Privi SpecialityChem is 60.6% and last quarter promoter holding is 60.6%.
Are mutual funds buying/selling Privi SpecialityChem?
The mutual fund holding of Privi SpecialityChem is decreasing. The current mutual fund holding in Privi SpecialityChem is 8.55% while previous quarter holding is 9.46%.